companydata.dkPHARMAORIGIN ApS: Financial statements 2017
CVR: 29178291
PHARMAORIGIN ApS (CVR 29178291) has filed annual accounts for 2017. In 2017, the company reported a net result of DKK -4,332,000 compared with DKK -1,713,000 the year before. Equity amounted to DKK 1,100,000. The solvency ratio was 100%.
- Profit/Loss
- -4,332,000 kr.
- Equity
- 1,100,000 kr.
- Total Assets
- 1,100,000 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | - | -4.3 mio. | 1.1 mio. | - |
| 2016 | - | - | -1.7 mio. | 5.4 mio. | - |
| 2015 | - | - | -135 t. | 4.2 mio. | - |
| 2014 | - | - | -558 t. | 4.3 mio. | - |
| 2013 | 0 | 0 | -938 t. | -132 t. | - |
Find more companies like PHARMAORIGIN ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2017
PHARMAORIGIN ApS has published its annual report for 2016. The net result was DKK -1,713,000.
As of June 1, 2017, David Lee Lowrance is registered as director of PHARMAORIGIN ApS.
About PHARMAORIGIN ApS
PHARMAORIGIN ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2005. The company is registered under the industry Drift af sundhedsvæsen i øvrigt i.a.n.. The company was previously named ApS KBUS 17 NR. 4503. The management consists of Danielle Marie Brown. The company is owned by Savara ApS. The company has 0 employees. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK 100,000 compared with DKK 94,000 the year before. Equity amounted to DKK 1,477,000.